Design of clinical trials to assess diabetes treatment: Minimum duration of continuous glucose monitoring data to estimate time‐in‐ranges with the desired precision
Aim To compute the uncertainty of time‐in‐ranges, such as time in range (TIR), time in tight
range (TITR), time below range (TBR) and time above range (TAR), to evaluate glucose …
range (TITR), time below range (TBR) and time above range (TAR), to evaluate glucose …
Comparison between closed-loop insulin delivery system (the Artificial Pancreas) and sensor-augmented pump therapy: A randomized-controlled crossover trial
Objective: Several studies have shown that closed-loop automated insulin delivery (the
artificial pancreas) improves glucose control compared with sensor-augmented pump …
artificial pancreas) improves glucose control compared with sensor-augmented pump …
An analytical approach to determine the optimal duration of continuous glucose monitoring data required to reliably estimate time in hypoglycemia
Diabetes is a chronic metabolic disease that causes blood glucose (BG) concentration to
make dangerous excursions outside its physiological range. Measuring the fraction of time …
make dangerous excursions outside its physiological range. Measuring the fraction of time …
A Mathematical Formula to Determine the Minimum Continuous Glucose Monitoring Duration to Assess Time-in-ranges: Sensitivity Analysis Over the Parameters
In diabetes management, the fraction of time spent with glucose concentration within the
physiological range of [70− 180] mg/dL, namely time in range (TIR) is often computed by …
physiological range of [70− 180] mg/dL, namely time in range (TIR) is often computed by …